PAD Profile : Naltrexone hydrochloride - Multiple sclerosis

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Naltrexone hydrochloride - Multiple sclerosis

PAD Profile : Naltrexone hydrochloride - Multiple sclerosis

Keywords :

MS, low dose naltrexone

Traffic Light Status

Status 1 of 1.

Status :

Non Formulary

Formulations :

Not Specified

Trust Alignment :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

BNF NICE SPC

Comments :

No comments returned.

Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Type

Document

Review Date

Evidence Review

Low dose naltrexone in MS - Evidence review for APC May10

Committee Recommendations

Date

Committee Name

Narrative

04 June 2010

Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The APC committee did not support the use of low dose naltrexone for MS and agreed that this would be added to NHS Surrey's Low Priority Procedure list as something that is not routinely funded.

Associated BNF Codes

01. Gastro-Intestinal System

01.06.06. Peripheral opioid-receptor antagonists